title: HPV9: Combating HPV-associated cancers by strengthening serotype defenses.
authors.affiliation: School of Pharmacy, University of Wisconsin-Madison, WI.
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Dougherty
authors.affiliation: School of Pharmacy, University of Wisconsin-Madison, WI.
authors.forename: Mary S
authors.initials: MS
authors.lastname: Hayney
mesh_terms: D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood; D003157:Community Pharmacy Services; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007114:Immunization; D008297:Male; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D010342:Patient Acceptance of Health Care; D010353:Patient Education as Topic; D010595:Pharmacists; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000379:methods*; D024382:Professional Role; D016896:Treatment Outcome
chemical_list: D000914:Antibodies, Viral; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18